Addex Therapeutics Ltd
ADXN
$7.10
-$0.2022-2.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.77M | 14.24M | -3.53M | -3.23M | -2.96M |
| Total Depreciation and Amortization | 61.90K | 124.30K | 3.40K | 89.70K | 3.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.09M | -14.80M | 374.00K | 646.00K | 581.00K |
| Change in Net Operating Assets | 152.30K | -2.61M | 643.80K | 1.79M | -171.10K |
| Cash from Operations | -460.80K | -3.05M | -2.51M | -703.60K | -2.55M |
| Capital Expenditure | -1.50K | -- | -- | -1.40K | -800.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.30K | 5.16M | -- | -- | -- |
| Cash from Investing | -6.80K | 5.16M | -- | -1.40K | -800.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.20K | -3.00K | -66.70K | -69.10K | -72.10K |
| Issuance of Common Stock | 2.20K | 400.00 | 236.80K | 38.10K | -- |
| Repurchase of Common Stock | 0.00 | -21.20K | -4.50K | -3.30K | -20.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -500.00 | -33.60K | -1.00K | -24.10K | -96.50K |
| Cash from Financing | -600.00 | -63.50K | 188.20K | -65.90K | -213.90K |
| Foreign Exchange rate Adjustments | -38.90K | 1.80K | 112.10K | -232.70K | 30.30K |
| Miscellaneous Cash Flow Adjustments | -- | 338.20K | -349.80K | -- | -- |
| Net Change in Cash | -507.10K | 2.39M | -2.56M | -1.00M | -2.73M |
